These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7214300)

  • 1. Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancer.
    Schnuda ND
    Cancer; 1980 Sep; 46(5):1164-73. PubMed ID: 7214300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.
    Cercek L; Cercek B; Franklin CI
    Br J Cancer; 1974 May; 29(5):345-52. PubMed ID: 4136566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour specificity of the SCM test for cancer diagnosis.
    Chaitchik S; Asher O; Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
    Balding P; Light PA; Preece AW
    Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
    Orjasaeter H; Jordfald G; Svendsen I
    Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the SCM test in cancer diagnosis.
    Atkinson RJ; Lowry WS; Strain P
    Cancer; 1983 Jul; 52(1):91-100. PubMed ID: 6342753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test).
    Pritchard JA; Sutherland WH
    Br J Cancer; 1978 Aug; 38(2):339-43. PubMed ID: 698051
    [No Abstract]   [Full Text] [Related]  

  • 8. The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.
    Mitchell H; Wood P; Pentycross CR; Abel E; Bagshawe KD
    Br J Cancer; 1980 May; 41(5):772-7. PubMed ID: 6158967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
    Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
    Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the SCM-test for the diagnosis of cancer.
    Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):187-93. PubMed ID: 6681765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between patients with malignant diseases and non-malignant diseases or healthy donors by changes of fluorescence polarization in the cytoplams of circulating lymphocytes.
    Hashimoto Y; Yamanaka T; Takaku F
    Gan; 1978 Apr; 69(2):145-9. PubMed ID: 680459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on fluorescence polarization of human blood lymphocytes (SCM test) using a Percoll gradient centrifugal separation method].
    Tenzaki T; Matsumoto J; Ishiguro T; Yoshida Y; Sugiyama S
    Rinsho Byori; 1984 Apr; 32(4):394-8. PubMed ID: 6088848
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in the diagnosis of colorectal carcinoma.
    Hocking GR; Rolland JM; Nairn RC; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR
    J Natl Cancer Inst; 1982 Apr; 68(4):579-83. PubMed ID: 6951073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.
    Cercek L; Cercek B
    Br J Cancer; 1976 May; 33(5):539-43. PubMed ID: 1276032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.
    Cercek L; Cercek B
    Eur J Cancer (1965); 1977 Sep; 13(9):903-15. PubMed ID: 334557
    [No Abstract]   [Full Text] [Related]  

  • 18. Adaptation of the cellscan technique for the SCM test in breast cancer.
    Rahmani H; Deutsch M; Ron I; Gerbat S; Tirosh R; Weinreb A; Chaitchik S; Lalchuk S
    Eur J Cancer; 1996 Sep; 32A(10):1758-65. PubMed ID: 8983287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified technique for the T-globulin cancer test.
    Tal C; Raychaudhuri A; Megel H; Herberman RB; Buncher CR
    J Natl Cancer Inst; 1973 Jul; 51(1):33-43. PubMed ID: 4720884
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
    Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
    Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.